Pricing Log in Create free account
Friday 6 November 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue
+8.00%
EPS
+10.2%
Free cash flow
−21.3%
Total debt
+7.42%

Quarter to September 2026, against a year earlier

271.68 6.80 +2.57%
Market cap
$43.7B
P/E
32.6×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

IQVIA Holdings Inc. 10-Q filed Oct 27, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed · accepted 5:07 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors
Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Jul 28, 2026: 1 added · 18 modified; 18 with only figures updated

  1. Modified · Cost of Revenues, exclusive of Depreciation and Amortization

    For the secondthird quarter of 2026, our cost of revenues, exclusive of depreciation and amortization increased $239203 million, or 8.97.4%, as compared to the same period in 2025. For the first sixnine months of 2026, our cost of revenues, exclusive of depreciation and amortization increased $504707 million, or 9.68.9%, as compared to the same period in 2025. The increase for both periods is primarily due to increases in compensation and related expenses, and reimbursed expenses, and other direct costs, all to support revenue growth.